focus -WSS

focus

author：fashion 2025-10-01 11:47:10 - browse：179

1:43Traders work on the floor of the New York Stock Exchange on July 12, 2023 in New York City.Spencer Platt/Getty Images

As long-standing recession alarms continue to blare from some forecasters, investors don’t appear to hear them.

The S&P 500 this year, when excluding the ten largest companies, stands at single-digit gains.

Looking ahead, Agati and Moya said they expect the stock market to decline over the remainder of the year, ending 2023 with positive but modest returns. The full economic cooling-off effects of central bank rate hikes have yet to take hold, they said, adding that inflation may not return to normal levels as soon as investors hope.

"The rally will stall out here," Moya said.

MORE: US economy 'quite resilient,' Fed Chair Jerome Powell says

Stoltzfus, however, said there's a "good chance" the stock market will end the year higher than it currently stands.

"We have maintained a fairly bullish posture," he said. "Where the market is trading right now would suggest to us that it has further to go this year."

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Elevance, private equity launch primary care company

focus

WSS

Study: People of West African ancestry at greater risk of cardiac amyloidosis

H5N1 communication has been strictly for the birds

Patient advocates sound warning on FDA proposal on salt intake

Evacuations in place as 3 wildfires burn in eastern Washington state

Sanofi strikes deal with Novavax, boosting the vaccine maker

Clinical trials must include more disabled people

hotspot

focus

MORE: US economy 'quite resilient,' Fed Chair Jerome Powell says

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Hilary may become 1st tropical storm to make landfall in California in 84 years

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The boys, now 6, who are gene therapy’s ‘edge case’ problem

The high cost of giving birth even with insurance

Liz Cheney makes 1st public comment since Trump's election interference indictments

In Memoriam: Notable people who died in 2023

Trump's false claims about Georgia's 2020 election long debunked

Novavax promises a turnaround & Lilly roils the obesity market

Living with Hashimoto's and celiac disease, and med school, too

leisure time

ProMED sees offers of support, but its future remains unclear

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Elevance, private equity launch primary care company

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

ActiGraph execs on goal of drug approvals with digital endpoints

leisure time

focus

focus

focus